Clinical Trial Results:
Calcipotriol plus Betamethasone Dipropionate Gel Compared to DAIVONEX/DOVONEX Scalp Solution in Patients with Scalp Psoriasis. A phase III study comparing a gel containing calcipotriol 50 mcg/g plus betamethasone 0.5 mg/g (as dipropionate) used once daily with calcipotriol 50 mcg/ml in scalp solution used twice daily, in the treatment of scalp psoriasis.
Summary
|
|
EudraCT number |
2005-002864-27 |
Trial protocol |
DK SE BE |
Global completion date |
17 May 2006
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
18 Dec 2016
|
First version publication date |
18 Dec 2016
|
Other versions |
|
Summary report(s) |
MBL 0503 INT |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.